Table 1 Clinical and pathological characteristics of CRC patients and healthy control
From: Multi-omics analysis of fecal samples in colorectal cancer Egyptians patients: a pilot study
Sample No. | Diagnosis | Treatment |
|---|---|---|
1 | Colectomy + CRC | Adjuvant Folfiri protocol (folinic acid, fluorouracil (5FU) and Irinotecan Hydrochloride |
2 | Colectomy then Follow up (stable stage) | Adjuvant Folfox protocol (folinic acid, fluorouracil (5FU) and oxaliplatin |
3 | liver metastatic colorectal cancer (LMCRC) | Folfox, folfiri, combined Xelox ( Capecitabine + Oxaliplatin) and Gemcitabine |
4 | Colectomy and developed recurrence | Folfox, folfiri, mitomycin C, combined Xelox and Gemcitabine and Avastin (Bevacizumab) as a target therapy |
5 | Healthy | N/A |